InvestorsHub Logo
Followers 42
Posts 4839
Boards Moderated 0
Alias Born 04/30/2005

Re: georgejjl post# 261841

Saturday, 08/01/2020 8:09:03 PM

Saturday, August 01, 2020 8:09:03 PM

Post# of 458120
Wow...that's hard to dispute! Well done, George.

***********************************************************************


If Anavex has answered the question regarding what is different about subject 107001 that makes her a super responder, then Anavex 2-73 will without a doubt become a super multi $Billion$ blockbuster drug.

Super Responder Subject 107001

RSBQ Total from 59 to 14 in just 7 weeks
RSBQ Hand Behaviours Subscale from 5 to zero in just 7 weeks
RSBQ Breathing Problems Subscale from 9 to 4 in just 7 weeks
% Change in Glutamate 66% reduction from baseline in just 7 week
CSHQ (Sleep) Total 20 in just 7 weeks
Glutamate µmol/L 11 µmol/L of Glutamate in just 7 weeks
% Change CSHQ Waking 1% decrease during the Night in just 7 weeks
% Change in RSBQ Total 76% reduction in just 7 weeks
% Change in GABA 80% increase in just 7 weeks

GABA increases substantially from baseline (VERY GOOD)
Glutamate decreases substantially from baseline (VERY GOOD)

See slides 5 through 13 inclusive at the following link notice Super Responder Subject 107001

https://seekingalpha.com/article/4294834-anavex-life-sciences-avxl-presents-6th-annual-european-rett-syndrome-conference-slideshow

https://www.anavex.com/wp-content/uploads/2019/09/ANAVEX2-73-RS-001-Finland-Conference-Sept-2019-Final.pdf

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News